The U.S. Food and Drug Administration on Monday approved a second nasal spray for reversing an opioid overdose. To be sold as ...
The Food and Drug Administration (FDA) approved a prescription nasal spray this week that can reverse opioid overdoses. Opvee ...
The FDA approved a new nasal spray to reverse the effects of an opioid overdose. Ready why the application for this drug was ...
The U.S. Food and Drug Administration has approved Brixadi (buprenorphine) extended-release injection to treat ...
The FDA approved Opvee nalmefene hydrochloride nasal spray for the emergency treatment of opioid overdoses from Opiant ...
Weishapl is uncertain just how much good the FDA approval will do for the ongoing opioid crisis. “It’s cool, but unless people get it for free, it’s not going to help,” he said.
“We’re not suffering from a naloxone shortage where we need to use an alternative,” he said. “We have plenty of it and it works perfectly well.” The FDA approval comes as drug overdose ...
After a more than 4-year battle, Plymouth Meeting biotechnology firm Braeburn Inc. has received FDA approval for its opioid ...
The head of the commission that manages Kentucky’s opioid-settlement money said Wednesday that the panel will “explore the ...
It’s not yet clear how the drug will be used differently than naloxone, and some experts see downsides to its longer-acting ...
Narcan nasal spray for the treatment of opioid overdoses PHOTO COURTESY OF LAIST.COM VIA STOCK PHOTO WASHINGTON (AP) – U.S.
The Food and Drug Administration on Monday approved Opvee, the first prescription nasal spray for opioid overdoses using nalmefene hydrochloride.
